Melinta Therapeutics Inc. buy Quitte
Start price
18.09.18
/
50%
€19.73
Target price
29.10.18
€31.57
Performance (%)
-42.40%
End price
29.10.18
€11.37
Summary
This prediction ended on 29.10.18 with a price of €11.37. Massive losses of -42.40% were the result for the BUY prediction by Quitte. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Melinta Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by Quitte for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
die kommt
https://www.streetinsider.com/Corporate+News//Melinta+Therapeutics+%28MLNT%29+Names+Peter+Milligan+as+CFO/14617554.html
(Vom Mitglied beendet)
Stopped prediction by Quitte for Melinta Therapeutics Inc.
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.44
06.01.20
06.01.20
-
09.01.20
09.01.20
1.35%
09.01.20
09.01.20
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.14
07.01.19
07.01.19
€13.53
08.07.19
08.07.19
25.78%
08.07.19
08.07.19
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.98
29.10.18
29.10.18
€22.55
07.01.19
07.01.19
-53.18%
07.01.19
07.01.19
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.28
18.09.18
18.09.18
€23.45
18.09.18
18.09.18
0.00%
18.09.18
18.09.18
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€64.48
30.12.16
30.12.16
€95.00
28.03.17
28.03.17
52.77%
28.03.17
28.03.17